Genome in a Bottle Consortium

Download Profile PDF
At a Glance
  • Status: Active Consortium
  • Year Launched: 2012
  • Initiating Organization: NIST
  • Initiator Type: Academia
  • No disease focus
  • Location: North America

Abstract

The Genome in a Bottle Consortium is a public-private-academic consortium initiated by National Institute of Standards and Technology (NIST) to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of whole human genome sequencing to clinical practice. The consortium was initiated in a set of meetings in 2011 and 2012, and it now holds biannual public workshops in January at Stanford University and in August at NIST in Gaithersburg, Md. 

Mission

The mission of the Genome in a Bottle Consortium is to develop reference standards, reference methods, and reference data to enable translation of whole human genome sequencing to clinical practice.

Consortium History

2011-2012: Consortium initiated

Data Sharing

Progress achieved by the consortium is regularly shared through webinars and the Google Group.

Points of Contact

Further information regarding the Genome in a Bottle Consortium can be attained through signing up for emails and joining the Google Group. Links available on the consortium homepage.

Sponsors & Partners

Advances in Biomedical Measurement Science program at Stanford University

Agilent Technologies

Life Technologies

Novartis

Last Updated: 04/18/2016
The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.
Register your consortium  
All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.